Mangoceuticals, Inc. financial data

Symbol
MGRX on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
15110 Dallas Pkwy, Suite 600, Dallas, TX
State of incorporation
Texas
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 93.5 %
Quick Ratio 2.32 %
Debt-to-equity 21.2 %
Return On Equity -243 % +22.9%
Return On Assets -201 %
Operating Margin -1.03K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.9M shares +78.9%
Common Stock, Shares, Outstanding 29.1M shares +74.3%
Entity Public Float 13.4M USD
Common Stock, Value, Issued 2.91K USD +74.3%
Weighted Average Number of Shares Outstanding, Basic 26.1M shares +65.5%
Weighted Average Number of Shares Outstanding, Diluted 26.1M shares +65.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 867K USD +15.5%
Cost of Revenue 156K USD +15.9%
General and Administrative Expense 4.25M USD +113%
Operating Income (Loss) -8.9M USD -37.1%
Nonoperating Income (Expense) -223K USD -2805%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.13M USD -40.5%
Net Income (Loss) Attributable to Parent -9.13M USD -40.1%
Earnings Per Share, Basic -0.39 USD/shares +25%
Earnings Per Share, Diluted -0.39 USD/shares +35.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 490K USD
Inventory, Net 14K USD -40.3%
Assets, Current 518K USD -82.9%
Property, Plant and Equipment, Net 3.31K USD -97%
Operating Lease, Right-of-Use Asset 90K USD -38.8%
Intangible Assets, Net (Excluding Goodwill) 14.6M USD
Assets 15.2M USD +362%
Liabilities, Current 1.38M USD +601%
Operating Lease, Liability, Noncurrent 30.1K USD -69.1%
Liabilities 1.41M USD +379%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.17K USD
Retained Earnings (Accumulated Deficit) -16M USD -133%
Stockholders' Equity Attributable to Parent 13.8M USD +361%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 13.8M USD +361%
Liabilities and Equity 15.2M USD +362%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -991K USD +45.2%
Net Cash Provided by (Used in) Financing Activities 268K USD -94.7%
Net Cash Provided by (Used in) Investing Activities -3.52K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 29.1M shares +74.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.11M USD +9834%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 490K USD -83.4%
Deferred Tax Assets, Valuation Allowance 11.2M USD +457%
Deferred Tax Assets, Gross 11.2M USD +457%
Operating Lease, Liability 97.5K USD -38.1%
Depreciation 6.22K USD +2.34%
Payments to Acquire Property, Plant, and Equipment 3.52K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.39M USD -4.73%
Lessee, Operating Lease, Liability, to be Paid 104K USD -40.5%
Operating Lease, Liability, Current 67.4K USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 67.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 67.6K USD -5.76%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.99K USD -63.9%
Deferred Tax Assets, Operating Loss Carryforwards 9.21M USD
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 30.3M USD +207%
Share-based Payment Arrangement, Expense 79.7K USD
Interest Expense 1.76K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%